Cambridge Heart HearTwave
This article was originally published in The Gray Sheet
Executive Summary
Shipments are expected in the third quarter of the firm's test to predict life threatening heart rhythm disturbances and sudden death. FDA's 510(k) clearance of the test, which measures Microvolt T-wave Alternans, is announced June 14